Cargando…

Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment

Breast cancer is the most common invasive tumor in women and the second leading cause of cancer-related death. Nanomedicine raises high expectations for millions of patients as it can provide better, more efficient, and affordable healthcare, and it has the potential to develop novel therapeutics fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Juan, Alberto, Cimas, Francisco J., Bravo, Iván, Pandiella, Atanasio, Ocaña, Alberto, Alonso-Moreno, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504566/
https://www.ncbi.nlm.nih.gov/pubmed/32825618
http://dx.doi.org/10.3390/ijms21176018